Home > Insider Trading > Filing (0000899243-20-014716)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596946	Quotient Ltd	QTNT	In Vitro & In Vivo Diagnostic Substances (2835)	264719797

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1604628	Jeremy Stackawitz	C/O Quotient Limited 28 Esplanade St Helier Y9 JE2 3QA	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2020-05-28	11,000	$7.41	142,926	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Ordinary Shares	Employee Stock Option (right to buy)	$11.92	2026-05-31	20,000	20,000	Direct
Ordinary Shares	Employee Stock Option (right to buy)	$15.17	2025-05-19	22,500	22,500	Direct
Ordinary Shares	Employee Stock Option (right to buy)	$8.00	2024-04-29	60,000	60,000	Direct
Ordinary Shares	Employee Stock Option (right to buy)	$7.58	2027-05-23	40,000	40,000	Direct
Ordinary Shares	Restricted Stock Units	$0.00		10,321	10,321	Direct
Ordinary Shares	Restricted Stock Units	$0.00		23,333	23,333	Direct
Ordinary Shares	Restricted Stock Units	$0.00		45,000	45,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2026-05-31	20,000	20,000	Direct
2025-05-19	22,500	22,500	Direct
2024-04-29	60,000	60,000	Direct
2027-05-23	40,000	40,000	Direct
	10,321	10,321	Direct
	23,333	23,333	Direct
	45,000	45,000	Direct

Footnotes

All 20,000 options have vested and remain exercisable.
All 22,500 options have vested and remain exercisable.
All 60,000 options have vested and remain exercisable.
All 40,000 options have vested and remain exercisable.
Restricted Stock Units convert into ordinary shares on a one-for-one basis.
On May 24, 2018, the Reporting Person was granted 30,961 Restricted Stock Units, of which 20,640 have vested and have been exercised. The remaining 10,321 Restricted Stock Units will vest on May 24, 2021.
On May 24, 2019, the Reporting Person was granted 35,000 Restricted Stock Units, of which 11,667 have vested and have been exercised. The remaining 23,333 will vest in two equal installments on May 24, 2021 and May 24, 2022.
On May 24, 2020, the Reporting Person was granted 45,000 Restricted Stock Units, vesting in three equal annual installments beginning May 24, 2021.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.32 to $7.53, inclusive. The Reporting Person undertakes to provide to Quotient Limited and any security holder of Quotient Limited, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (10) to this Form 4.